viningocouqyl1601.blogspot.com
Baldino had been on the ViroPharma (NASDAQ:VPHM) board from 1996 to 2006. ViroPharmsa is an Exton, Pa.-based biopharmaceutical Last week it announced that the wantws an additional clinical study on its experimentapl hereditaryangiodema (HAE) drug Cinryze befores the agency will render a HAE is a rare, condition that causes swelling in various body parts includint the hands, feet, face and throat. The drug is alreadgy approved for use in preventingHAE ViroPharma’s other approved drug is Vancocin, an antibiotif used to treat bacteria infections of the lower digestive tracf that result in a potentially fatal condition known as clostridium difficile-associated disease.
Cephalon is an international company that focusesx on developing drugs in four coretherapeutic areas: central nervouw system, pain, oncology and addiction. Baldino sits on several otherr boards, including the trustees at Temple University, the Franklinh science museum and the Greater Philadelphia Chamberof Commerce.
No comments:
Post a Comment